Jiangsu Senxuan Pharmaceutical Co., Ltd.
  • Home

  • About Us

      About Us
      • Company Introduction

      • Subsidiary

      • Enterprise leadership

      • Enterprise culture

      • Qualifications and Honors

      About Us
  • Products

      Products
      • Chemical active pharmaceutical ingredients

      • Dioxane

      • Dioxolane

      • Ritonavir intermediates

      • Pharmaceutical intermediates

      • Products under development

      Products
  • Company News

  • Contact Us

Jiangsu Senxuan Pharmaceutical Co., Ltd. Language ▼

中文版

English

新闻资讯

新闻资讯

Company News

一图了解北交所

20

2022

/

06

北交所来了,与沪深交易所有哪些不同?

20

2022

/

06

新《证券法》下的投资者保护

20

2022

/

06

监事会议事规则(2022年4月)

20

2022

/

06

董事会议事规则(2022年4月)

20

2022

/

06

股东大会议事规则(2022年4月)

20

2022

/

06

2022-06-10 [临时公告]森萱医药:关于完成工商变更登记并取得营业执照的公告

20

2022

/

06

江苏森萱医药股份有限公司章程(2022年4月)

15

2022

/

06

Jiangsu Senxuan Pharmaceutical Co., Ltd. First Quarter Report 2022

05

2022

/

05

Jiangsu Senxuan Pharmaceutical Co., Ltd. Annual Report 2021

30

2022

/

03

Jiangsu Senxuan Pharmaceutical Co., Ltd. Third Quarter Report 2021

29

2021

/

10

Jiangsu Senxuan Pharmaceutical Co., Ltd. Semi-Annual Report 2021

02

2021

/

09

< 1...10111213 >

QR code

Public Number
  • Home

  • About Us

    • Company Introduction

    • Subsidiary

    • Enterprise leadership

    • Enterprise culture

    • Qualifications and Honors

  • Products

    • Chemical active pharmaceutical ingredients

    • Dioxane

    • Dioxolane

    • Ritonavir intermediates

    • Pharmaceutical intermediates

    • Products under development

  • Company News

  • Contact Us

JIANGSU SENXUAN PHARMACEUTICAL CO., LTD

Tel:
+86-513-85609405

+86-513-85609406

Fax: +86-513-85609407

E-mail:
nanjing@senxuan.cn sales1@ntjh.cn
Website: www.senxuan.cn
Office address: Floor 21, Building A, Guocheng Life Plaza, 198 Qingnian Middle Road, Nantong, Jiangsu 

Copyright © 2023 Jiangsu Senxuan Pharmaceutical Co., Ltd.

Label | Powered by www.300.cn

Business License